The grand global pharmaceutical industry event CPHI & PMEC China 2025 was successfully held in Shanghai from June 24 to 26. As a professional service provider in the field of UV photocatalysis technology, Priest showcased a variety of industrially validated UV photochemical equipment, high-efficiency reactors and customized solutions supported by solid technical reserves and mature industry application experience. The booth drew numerous well-known pharmaceutical manufacturers and exhibitors for in-depth communication and negotiations, fully demonstrating Priest’s leading technical strength in this sector.
During the exhibition, Priest’s technical team shared multiple application cases with visiting clients, including a customized small-scale photochemical unit recently delivered to a listed pharmaceutical enterprise in Jiangxi Province. The equipment has been officially put into vitamin synthesis production. Its stable operation and excellent process adaptability have proven the practical value of Priest’s UV photocatalysis technology for pharmaceutical manufacturing processes, attracting extensive attention and discussion among pharmaceutical representatives on site.
Innovative Technology Draws Wide Attention; UV Photocatalysis Fuels Pharmaceutical Industry Upgrade
At the booth, Ms. Liu Yuelin, Chief Engineer of Priest, together with the business team, elaborated on the prominent advantages of UV photocatalysis in drug synthesis, microbial sterilization, TOC degradation and pharmaceutical waste gas treatment for visiting customers. Compared with conventional pharmaceutical processes, Priest’s UV photocatalysis technology boasts the following core competitive edges:
- High Efficiency & Eco-friendliness: Photocatalytic reactions significantly boost drug synthesis yield and cut waste emissions, aligning with the trend of green pharmaceutical manufacturing.
- Flexible Compatibility: A full range of self-developed reactors enables tailor-made solutions for diverse pharmaceutical scenarios to meet varied production demands.
- Disruptive Advantages: The innovative technology replaces high-energy-consuming and costly traditional processes, offering pharmaceutical manufacturers a new approach to cost reduction and efficiency improvement.
Leveraging profound professional expertise and abundant industrial experience, Chief Engineer Liu delivered comprehensive, in-depth explanations covering technical principles and practical implementation, winning high recognition from all visiting clients.
Customized Services Fully Validated; Specialized Equipment Successfully Delivered to Jiangxi Pharmaceutical Manufacturer
Concurrent with the exhibition, a custom small photochemical device developed by Priest for a renowned listed pharmaceutical enterprise in Jiangxi was fully delivered and commissioned for vitamin synthesis. Developed around the client’s actual production requirements, the equipment embodies Priest’s comprehensive capabilities in process matching, technical reliability and on-time delivery execution. This cooperation not only supplied the client with an energy-efficient high-yield synthesis solution, but also set a benchmark case for the application of UV photocatalysis technology in vitamin production across the industry.
Professional Expertise Widely Recognized; In-depth Follow-up Cooperation in the Pipeline
Priest’s booth hosted representatives from dozens of famous domestic and overseas pharmaceutical manufacturers throughout the show. Many enterprises reached preliminary deep cooperation intentions with Chief Engineer Liu regarding the on-site implementation of UV photocatalysis technology. Constrained by limited exhibition time, numerous clients scheduled post-show factory visits to further inspect Priest’s R&D capacity and technical achievements, jointly exploring innovative paths to upgrade pharmaceutical manufacturing workflows.
Technology Powers Future Progress; Priest Drives Industrial Transformation
Beyond showcasing its deep technical accumulation in UV photocatalysis, Priest clarified market demands and technological trends through extensive exchanges with industry peers at this exhibition. Moving forward, the company will continuously increase investment in R&D, empowering pharmaceutical manufacturers to break through production bottlenecks and achieve sustainable development with more efficient, eco-friendly solutions.